1.25 mg of tirzepatide / Niacinamide Injection Tirzepatide Instructions | Allure Medical

If you're still in dose escalation or have not yet reached a therapeutic dose, continue the protocol as prescribed by your provider

Powerful Antioxidant Blend

Patients using GLP-1 medications experienced a 7% lower medical cost trend by year two compared to similar patients who did not receive obesity treatment

Canada GLP-1 Receptor Agonist Market Analysis The GLP-1 receptor agonist market in Canada was valued at USD 4.35 billion in 2025, supported by increasing prevalence of obesity and type 2 diabetes, expanding access to innovative diabetes therapies, and growing emphasis on chronic disease management

Sci Rep (2019) 9(1):7519

Beck and the team monitor your progress and ensure your health and safety during your weight-loss efforts